Mackay Sean
- SEC CIK
- 0001875501
No open-market purchases or sales filed in the past year.
Current role at each company
- LAB Standard Biotools Inc.SVP & Chief Business Officeras of Aug 24, 2026
- ISO IsoPlexis CorpChief Executive Officeras of Mar 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mackay Sean as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LAB Standard Biotools Inc.
SVP & Chief Business Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 (view filing) | May 23 | 5 days | Mackay SeanSVP & Chief Business Officer | SSale | −13.2K | $0.94 | −$12.4K | −1.5%843.1K after | |
| May 23, 2025 (view filing) | May 21-22 | 2 days | Mackay SeanSVP & Chief Business Officer | SSale | −25.4K | $1.02 | −$25.8K | −2.9%856.3K after | 2 lots |
ISO IsoPlexis Corp
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2022 (view filing) | Aug 25 | 4 days | Mackay SeanChief Executive Officer | PPurchase | +15.0K | $1.99 | +$29.9K | +1.7%914.4K after |